Navigation Links
Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
Date:1/22/2009

Conference Call Scheduled for 5:00 p.m. ET

ORANGE COUNTY, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC) announced today it will host a conference call on Monday, February 9, 2009, at 5:00 p.m. ET to discuss the company's fourth quarter and full year 2008 results. Earnings will be released after the market closes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The call may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation number 82436122.

There also will be a live webcast of the call. It will be accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com. When accessing the webcast through the Beckman Coulter site, select "go to IR" under "Investor Relations" and find the call listed under "What's Ahead." The webcast will be archived on both websites for future on-demand replay.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating type lease payments, represent more than 78 percent of the company's 2007 revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.

    Contact Information
    Cynthia Skoglund    (714) 773-8213
    cgskoglund@beckman.com


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
2. Beckman Coulter to Host Annual Business Review
3. Beckman Coulter to Present at Upcoming Healthcare Conferences
4. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
5. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
6. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
7. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
8. Beckman Coulter Investor Events Second Half of 2008
9. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
10. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
11. Beckman Coulter Announces Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... and scientists from around the world, was today awarded the "Best Science & ... based entirely on merit and decided upon by a dedicated team of researchers ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
(Date:1/18/2017)... -- According to a new market research report "In situ Hybridization ... End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to ... by 2021 from USD 557.1 Million in 2016, growing at a CAGR of ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/19/2017)... , Jan. 19, 2017 ... user experience and security for consumer electronics, and ... payment processing systems and cybersecurity solutions, today announced ... enterprises and financial institutions worldwide to bolster security ... the end-to-end secure user authentication platforms they offer, ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
Breaking Biology News(10 mins):